A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames

Journal of Immunology

Volumn 161, Issue 7, 1998, Pages 3596-3606

  Wang, Rong Fu ^a   Johnston, Samuel L ^a   Zeng, Gang ^a   Topalian, Suzanne L ^a   Schwartzentruber, Douglas J ^a   Rosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; TUMOR ANTIGEN; CTAG1B PROTEIN, HUMAN; HLA A ANTIGEN; HLA A31; HLA-A31; MEMBRANE PROTEIN; PEPTIDE; PROTEIN;

ANTIGEN SPECIFICITY; ARTICLE; BREAST TUMOR; DNA LIBRARY; ESOPHAGUS CANCER; GENE EXPRESSION; GENE ISOLATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYSIS; MELANOMA; NORTHERN BLOTTING; OPEN READING FRAME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TARGET CELL; TUMOR IMMUNOLOGY; AMINO ACID SEQUENCE; CELL CLONE; CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; GENETICS; IMMUNOLOGY; MELANOCYTE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; TUMOR GENE;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; BASE SEQUENCE; BREAST NEOPLASMS; CLONE CELLS; GENES, NEOPLASM; HLA-A ANTIGENS; HUMANS; MELANOCYTES; MELANOMA; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PEPTIDES; PROTEIN BIOSYNTHESIS; PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0032186274     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Rosenberg, S. A., B. S. Packard, P. M. Aebersold, D. Solomon, S. L. Topalian, S. T. Toy, P. Simon, M. T. Lotze, J. C. Yang, C. A. Seipp, et al. 1988. Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. Preliminary report. N. Engl. J. Med. 319:1676.
2. Rosenberg, S. A., J. Y. Yannelli, and J. C. Yang. 1994. Treatment of patients with metastatic melanoma using autologous tumor-infiltrating lymphocytes and interleukin-2. J. Natl. Cancer Inst. 86:1159.
3. Boon, T., J.-C. Cerottini, B. Van den Eynde, P. van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12: 337.
4. Houghton, A. N. 1994. Commentary: cancer antigens: immune recognition of self and alterted self. J. Exp. Med. 180:1.
5. Tsomides, T. J., and H. N. Eisen. 1994. Commentary: T-cell antigens in cancer. Proc. Natl. Acad. Sci. USA 91:3487.
6. Pardoll, D. M. 1994. News and views: a new look for the 1990s. Nature 369:357.
7. Wang, R.-F., and S. A. Rosenberg. 1996. Human tumor antigens recognized by T lymphocytes: implications for cancer therapy. J. Leukocyte Biol. 60:296.
8. Rosenberg, S. A. 1997. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol. Today 18:175.
9. van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. DePlaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643.
10. Gaugler, B., B. Van den Eynde, P. van der Bruggen, P. Romero, J. J. Gaforio, E. De Plaen, B. Lethe, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179:921.
11. Van Den Eynde, B., O. Peelers, O. De Backer, B. Gaugler, S. Lucas, and T. Boon. 1995. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182:689.
12. Boël, P., C. Wildmann, M. L. Sensi, R. Brasseur, J. C. Renauld, P. Coulie, T. Boon, and P. Van der Bruggen. 1995. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2:167.